Chronic Methamphetamine Administration Increases Mitochondrial Density and Impairs Mitochondrial Function in the Substantia Nigra Pars Compacta
Aishwarya Bhowmik, Jennifer A. Wilking, Duha Alshareef, Colin Campbell, Steven M. Graves · 2026
Read Chronic Methamphetamine Administration Increases Mitochondrial Density and Impairs Mitochondrial Function in the Substantia Nigra Pars Compacta by Aishwarya Bhowmik, Jennifer A. Wilking, Duha Alshareef, Colin Campbell, Steven M. Graves (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13613010.txt.
Description
Aishwarya Bhowmik and four co-authors examine what chronic methamphetamine does to brain mitochondria in a 2026 paper. The drug kills dopamine neurons in the substantia nigra, the region lost in Parkinson's disease, through oxidative stress driven by one enzyme. Whether the neurons' power plants pile up or break down during chronic exposure was unclear.
Male mice received the drug or saline daily for twenty-eight days. Two proteins that run mitochondrial recycling fell in the target region, hinting the cleanup system was impaired. Sure enough, mitochondrial density inside dopamine neurons rose, and the rise depended on the same enzyme tied to the damage. Breathing tests on the tissue then checked whether the extra mitochondria actually worked. The emerging picture is a traffic jam: damaged power plants accumulate because disposal falters, stressing the very neurons the drug destroys. The study links a street drug's toxicity to a Parkinson's-like cellular failure.
Catalog record
| CREATOR | Aishwarya Bhowmik, Jennifer A. Wilking, Duha Alshareef, Colin Campbell, Steven M. Graves |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 50 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |